Position of the hypertension and vascular damage working group from the argentinian society of nephrology and from the hypertension and vascular damage council of the nephrological association of Buenos Aires towards hypertensive patients undergoing treatment with drugs acting on the renin-angiotensinaldosterone system and COVID-19

Carlos Blanco; Dennis Bueno; Gustavo Lavenia; Cristian Kramer; Felipe Inserra; Leonardo Sivak

2020, Number 3

Next >>

Rev Nefrol Dial Traspl 2020; 40 (3)

Position of the hypertension and vascular damage working group from the argentinian society of nephrology and from the hypertension and vascular damage council of the nephrological association of Buenos Aires towards hypertensive patients undergoing treatment with drugs acting on the renin-angiotensinaldosterone system and COVID-19

Blanco C, Bueno D, Lavenia G, Kramer C, Inserra F, Sivak L

Full text

How to cite this article

Language: Spanish
References: 8
Page: 191-193
PDF size: 225.22 Kb.

Text Extraction

No abstract.

REFERENCES

O’Mara GJ. Could ACE inhibitors, and particularlyARBs, Increase susceptibility to COVID-19 infection?Response to the emerging novel coronavirus outbreak.BMJ. 2020;368:m406. doi: 10.1136/bmj.m406.
Sriram K, Insel PA. Dangers of ACE inhibitor andARB usage in COVID-19: evaluating the evidence[preprint]. medRxiv. Posted Apr 20, 2020. doi: https://doi.org/10.1101/2020.03.25.20043927.
De Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, et al. Use ofrenin–angiotensin–aldosterone system inhibitors andrisk of COVID-19 requiring admission to hospital:a case-population study. Lancet. May 14, 2020. doi:10.1016/S0140-6736(20)31030-8.
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, etal. A crucial role of angiotensin converting enzyme 2(ACE2) in SARS coronavirus–induced lung injury.Nature Med. 2005;11(8):875-9.
Imai Y, Kuba K, Rao S, Guo F, Guan V, Yang P, et al.Angiotensin-converting enzyme 2 protects from severeacute lung failure. Nature. 2005;436(7047):1126.doi:10.1038/nature03712.
Zhang H, Baker A. Recombinant human ACE2:acing out angiotensin II in ARDS therapy. Crit Care.2017;21(1):305. doi:10.1186/s13054-017-1882-z.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN, et al.Cardiovascular disease, drug therapy, and mortality inCovid-19 [published online 2020 May 1, and updatedon May 8]. N Engl J Med. 2020; NEJMoa2007621.doi: 10.1056/NEJMoa2007621.
Chung SC, Providencia R, Sofat R. Associationbetween Angiotensin Blockade and Incidence ofInfluenza in the United Kingdom [published online2020 May 8]. N Engl J Med. 2020;NEJMc2005396.doi:10.1056/NEJMc2005396.